What opioid conversion means in clinical practice
Clinicians often need to compare or switch between opioid analgesics. Because opioids differ in potency, receptor effects, pharmacokinetics, and formulation, a milligram-for-milligram substitution is rarely appropriate. Instead, conversions rely on equianalgesic estimates: doses that aim for similar overall opioid effect for an “average” patient under specified assumptions (typically oral dosing and population-average potency tables).
The Opiate Conversion Calculator on CalcMD implements a transparent version of this workflow using morphine milligram equivalents (MME), a widely used scaling system that expresses different opioids on a common morphine reference scale. The tool is intended for education and communication—for example, understanding relative potency, teaching MME concepts, or generating a starting estimate that must still be individualized at the bedside.
Why MME is used as a common reference
MME summarizes opioid exposure in units tied to oral morphine. Each opioid is assigned an MME conversion factor expressed as MME per milligram of drug (for oral products in this calculator). Multiplying a patient’s dose (in mg) by that factor yields an approximate total daily MME for that component of therapy—before adjustments for incomplete cross-tolerance, organ dysfunction, age, sleep-disordered breathing, concurrent sedatives, or formulation differences.
Using a single reference axis (morphine) makes it easier to reason across agents. It also aligns with how many health systems document opioid burden for safety monitoring, care transitions, and quality reporting. However, MME is a practical scaling tool, not a precise measure of “true” analgesia or respiratory risk in every patient.
How the calculator performs the conversion
The mathematics mirrors the steroid equivalency pattern used elsewhere on CalcMD: first express the original drug in a shared unit (here, total MME), then translate that total into the target drug’s milligrams.
- Normalize units to milligrams. If you enter grams or micrograms, the tool converts to mg before applying MME factors.
- Compute total MME from the source opioid. Conceptually:
Total MME = dose (mg) × MME factor (per mg) of the source opioid. - Convert MME to the target opioid dose. Conceptually:
Target dose (mg) = Total MME ÷ MME factor (per mg) of the target opioid.
Algebraically, this is equivalent to multiplying the original dose by the ratio of factors:
Target dose ≈ Original dose × (MME factor from ÷ MME factor to)
The interface also reports a dose multiplier (the factor ratio) and the total MME so you can see both the direct scaling relationship and the underlying “morphine-equivalent load” implied by the entered dose.
MME factors used for common oral opioids in this tool
The calculator includes a focused set of frequently encountered oral agents. The factors below are the ones applied in the tool for equianalgesic estimation:
| Opioid (oral, as implemented) | MME per 1 mg |
|---|---|
| Morphine (oral) | 1 |
| Codeine | 0.15 |
| Hydrocodone | 1 |
| Hydromorphone (oral) | 4 |
| Oxycodone | 1.5 |
| Oxymorphone | 3 |
| Tramadol | 0.1 |
| Tapentadol | 0.4 |
These values follow commonly published oral MME conversion factors used in clinical references and public health prescribing materials. They represent population averages for communication and safety awareness, not patient-specific pharmacology.
Worked example (for intuition)
Suppose a patient is taking 10 mg of oral hydrocodone and you want an approximate oral oxycodone dose using the same MME framework. Hydrocodone is modeled at 1 MME per mg, yielding 10 MME. Oxycodone is modeled at 1.5 MME per mg, so:
10 MME ÷ 1.5 ≈ 6.67 mg oxycodone (oral)
This illustrates how a smaller milligram amount of oxycodone can carry similar MME burden to a larger milligram amount of hydrocodone, reflecting relative potency assumptions embedded in the table.
What the estimate does and does not assume
Assumptions baked into a simple MME crosswalk
- Oral route consistency: The tool is designed around oral MME factors. Parenteral, transdermal, sublingual/buccal, or neuraxial routes have different bioavailability and risk profiles and should not be substituted without route-specific guidance.
- Single-agent arithmetic: The conversion addresses one opioid at a time. Real patients may be on combinations, partial agonists, or long-acting matrices that require separate clinical rules.
- Average potency: MME factors do not capture genetic variability, drug interactions, malabsorption, or tolerance state.
Agents and situations not adequately represented by a flat factor
Some opioids are intentionally excluded from this calculator because a single mg-based multiplier is misleading:
- Methadone: Equianalgesic ratios are not stable across dose ranges and clinical context.
- Buprenorphine: Partial agonism and ceiling effects break simple MME scaling for many clinical questions.
- Transdermal fentanyl: Requires patch-based conversions and careful titration rules, not a simple oral mg crosswalk.
Opioid rotation: why calculated equianalgesic doses are usually reduced
When switching opioids, many references recommend starting with a fraction of the calculated equianalgesic dose because of incomplete cross-tolerance and differing efficacies at the patient level. A calculated number can therefore overestimate the dose needed—or dangerously underestimate risk if interpreted as automatically “safe.”
Practical rotation typically combines a conservative starting point, frequent reassessment of analgesia and adverse effects, and structured monitoring—especially for sedation, confusion, constipation, and respiratory depression.
Safety considerations beyond the number
- Respiratory depression risk rises with opioid dose, advanced age, pulmonary disease, obstructive sleep apnea, and concurrent benzodiazepines, gabapentinoids, alcohol, and other sedatives.
- Renal or hepatic impairment can markedly change active metabolite accumulation (notably relevant for some agents and metabolites).
- Tramadol and tapentadol carry additional pharmacologic considerations (including interaction risks) that are not fully captured by MME alone.
- Regulatory and institutional policies may define MME thresholds or monitoring requirements; local protocols should govern prescribing documentation and workflows.
How to use this tool responsibly on CalcMD
Use the calculator to build understanding of relative potency and to sanity-check orders in a teaching or preparatory setting. Any output should be interpreted as an approximation requiring clinical judgment, patient-specific assessment, and adherence to applicable laws, prescribing rules, and electronic health record safety checks.